Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   8-K10-Q10-Q10-K10-Q10-Q10-Q10-K
CASH FLOWS FROM OPERATING ACTIVITIES:          
    Net income (loss)   54.139.3-64.110.8832.1790.0854.0
    Adjustments to reconcile net income (loss) to net cash from operating activities:          
        Depreciation and amortization   105.4107.4108.0109.4109.2107.2105.2
        Non-cash interest expense   4.14.14.14.99.112.916.5
        Amortization of premium on investments   6.36.15.23.72.41.20.6
        Stock-based compensation   187.8195.6197.3201.0202.1192.2189.7
        Gain on sale of nonfinancial assets, net   -108.0     -52.8
        Deferred income taxes   -13.4-14.1-15.6-47.8-882.9-897.3-890.0
        Unrealized foreign exchange loss (gain)   -13.1-12.6-1.8-2.44.82.68.0
        Non-cash changes in the fair value of contingent consideration   4.97.88.09.49.66.84.5
        Other   -2.3-1.1-2.6-2.7-0.7-1.5-1.0
        Changes in operating assets and liabilities:          
            Accounts receivable, net   -44.4-29.565.639.4-33.613.2-59.0
            Inventory   -42.9-27.5-35.1-7.0-8.5-46.9-61.2
            Other current assets   -16.6-21.029.812.532.252.818.3
            Other assets   2.2-6.8-6.6-23.9-23.1-26.9-29.0
            Accounts payable and other short-term liabilities   0.29.915.7-18.0-53.5-64.6-87.0
            Other long-term liabilities   -5.5-3.9-3.3-16.0-12.4-9.9-7.0
                Net cash provided by operating activities   119.0145.6304.5280.0269.1214.185.4
   
CASH FLOWS FROM INVESTING ACTIVITIES:          
    Purchases of property, plant and equipment   -103.4-98.9-95.6-97.9-95.7-99.3-114.3
    Maturities and sales of investments   653.7652.2691.0712.7734.7655.8555.8
    Purchases of investments   -1,241.9 -1,421.7 -1,014.2 -529.7
    Proceeds from sale of nonfinancial assets    110.0     
    Purchase of intangible assets   -20.0-22.8-23.6-16.9-18.8-22.5-23.2
    Other      -1.0-0.9 -0.7
        Net cash used in investing activities   -117.2-207.7-366.3-299.9-73.3-201.8-53.6
   
CASH FLOWS FROM FINANCING ACTIVITIES:          
    Proceeds from exercises of awards under equity incentive plans   51.051.649.244.552.667.671.9
    Taxes paid related to net share settlement of equity awards   -51.5-49.7-45.8-46.4-46.7-44.9-44.6
    Repayments of convertible debt         -375.0
    Principal repayments of financing leases   -2.2-2.5-3.0-3.3-6.8-8.0 
    Other     -0.4-0.4-0.4  
        Net cash provided by (used in) financing activities   -23.7-1.00.0-380.6-376.3176.4181.1
   
Cash and cash equivalents:          
    SUPPLEMENTAL CASH FLOW DISCLOSURES:          
        Cash paid for interest   10.310.410.413.213.212.212.2
        Cash paid for income taxes   19.816.518.220.216.29.79.0
        SUPPLEMENTAL CASH FLOW DISCLOSURES FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:          
            Increase (decrease) in accounts payable and accrued liabilities related to intangible assets         -0.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy